MNK cashing up again?, page-10

NOT really ever seen the "mystery" some have in what MNK is really about....they know that staying with the current crowd, in the "pills-n-potions" market, is simply pointless for them and therefore their stockholders. They'll only ever be a 2nd-tier player, in an increasingly crowded and THIN mature market.

They clearly have a "go-getter" exec team and they've decided medicine is ultimately a technology driven industry and they need to be on the newgen wave to rise above the crowed-old technology sector.

Anyone with some real ambition and a desire to spend the next decade working their strategy hard would do exactly this.....MSB is well positioned to partner with them, on at least a couple of major programs.

n some respects - very different sure - but generally speaking, you kind of see where CSL was say 15yrs ago. Long established name, but not focused on the growth sectors......they changed that and no-reason MNK can't!